EXICURE, INC. Stock Split Ratio
EXICURE, INC. (XCUR) had Stock Split Ratio of 20.00% as of 2024-08-27, per its 10-Q filed 2025-08-08.
Financial Statements › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-08-08
- 2024-08-27: Stockholders' Equity Note, Stock Split, Conversion Ratio 20.00%.
- 2024-08-20: Stockholders' Equity Note, Stock Split, Conversion Ratio 20.00%.
- 2022-06-29: Stockholders' Equity Note, Stock Split, Conversion Ratio 3.33%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2024-08-27 | 20.00% 10-Q · filed 2025-08-08 |
| 2024-08-20 | 20.00% 10-K · filed 2025-03-18 |
| 2022-06-29 | 3.33% 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |